One study used a different hypermethylated gene panel (RASSF1A, ESR1, CDH1, TIMP3, SYK) in the hopes of finding more concordant data; however, only 17% of patients in that study had simultaneous methylation of a gene in the tumor and in the blood [112]. Here, RASSF1 is linked to neoplasm.